Comorbidities in Privately Insured South Africans With Systemic Lupus Erythematosus.

Journal: Cureus

Volume: 16

Issue: 3

Year of Publication: 

Affiliated Institutions:  Department of Internal Medicine, School of Clinical Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, Johannesburg, ZAF. Division of Rheumatology, Department of Internal Medicine, School of Clinical Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, Johannesburg, ZAF. School of Public Health, University of the Witwatersrand, Johannesburg, Johannesburg, ZAF.

Abstract summary 

Introduction Comorbidities in systemic lupus erythematosus (SLE) impact negatively on health-related quality of life (HRQoL) and life expectancy. We investigated the frequency and spectrum of comorbidities in privately insured South Africans with SLE. Methods The data of SLE patients based on International Classification of Diseases, Tenth Revision (ICD-10) codes and insured with Discovery Health Medical Scheme (DHMS), South Africa, aged ≥16 years at diagnosis and with ≥6 months of follow-up were reviewed. Demographics, comorbidities listed in the Charlson comorbidity index (CCI), other common comorbidities, intercurrent illnesses, and drug therapy were documented. Results Of the 520 patients coded as SLE, 207 met the inclusion criteria. Most were females (90.8%), with a median (interquartile range {IQR}) age and follow-up duration of 39 (30.3-53.0) and 6.1 (3.7-8.1) years, respectively. All patients had at least one comorbidity; the most frequent CCI comorbidities were pulmonary disease (30.9%), congestive heart failure (CHF, 15%), and renal disease (14.0%). Other common comorbidities were hypertension (53.1%) and mood and anxiety disorders (46.9%). Urinary tract infections (UTIs, 37.7%) and pneumonia (33.8%) were common intercurrent illnesses. The independent predictors of CHF were renal disease (odds ratio {OR}=855), dyslipidemia (OR=15.3), and male gender (OR=43.0); the independent predictors of hypertension were age at diagnosis (OR=1.03), type 2 diabetes (OR=4.45), and renal disease (OR=4.34); and the independent predictors of mood and anxiety disorders were female gender (OR=3.98), stroke (OR=3.18), UTI (OR=2.39), and chloroquine use (OR=1.94). Conclusion In this study of privately insured South Africans with SLE, comorbidities were common, and all patients had at least one comorbidity. Hypertension, infections, and mood and anxiety disorders were the leading comorbidities overall, and pulmonary disease was the most common CCI comorbidity. There is an obvious need to formally study the burden of mental health disorders in South African SLE patients.

Authors & Co-authors:  Ngandu Ntumba Mbombo Henriette MH Makan Kavita K Musenge Eustasius E Tikly Mohammed M

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. Urowitz MB, Gladman DD, Tom BD, Ibañez D, Farewell VT. J Rheumatol. 2008;35:2152–2158.
Authors :  4
Identifiers
Doi : e55470
SSN : 2168-8184
Study Population
Male,Female,Females
Mesh Terms
Other Terms
africa;comorbidities;hypertension;infections;private sector;systemic lupus erythematosus
Study Design
Cross Sectional Study
Study Approach
Systemic Review
Country of Study
South Africa
Publication Country
United States